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ABSTRACT
Objective: To describe the associations between leptin,
body composition, sex and knee cartilage volume/defects
in older adults.
Methods: A cross-sectional sample of 190 randomly
selected subjects (mean 63 years, range 52–78, 48%
female) were studied. Knee cartilage volume and defects
were determined using T1-weighted fat saturation MRI.
Serum leptin levels were measured by radioimmunoassay.
Fat and lean mass were measured by dual energy x ray
absorptiometry (DXA). Body mass index (BMI) was
calculated.
Results: In multivariable analysis, serum levels of leptin
were negatively associated with total cartilage volume (b:
2541 mm3/log transformed unit, 95% CI 2861 to2221)
but not with prevalent knee cartilage defects. BMI was
negatively associated with cartilage volume after adjust-
ment for total lean mass and positively with prevalent
knee cartilage defects. However, the association between
BMI and cartilage volume disappeared after adjustment
for leptin while the association between BMI and cartilage
defects remained unchanged. Lastly, sex differences in
total cartilage volume decreased substantially after
adjustment for leptin (R2 from 51% to 30%).
Conclusions: This cross-sectional study suggests carti-
lage volume loss with obesity and female sex is related to
leptin and, thus, is hormonally mediated in older adults. By
contrast, obesity related knee focal cartilage defects may
be more related to non-hormonal factors.
Osteoarthritis (OA) is a slowly progressive disease
characterised by gradual loss of articular cartilage
with a multifactorial cause. It is well established
that obesity and female sex are risk factors for knee
OA;1–3 however, the underlying mechanism
remains obscure but may involve biomechanical
processes4 or variations in sex hormones.2 Although
there has been little evidence to show a metabolic
link between obesity and knee OA,3 5 recent
hypothetical arguments propose that leptin may
represent a systemic factor linking obesity, sex and
knee OA.6 7 Leptin, a 16 kDa non-glycosylated
protein encoded by the gene obese (ob), is a
hormone secreted mainly by adipocytes8 as well
as osteoblasts and chondrocytes.7 9 Leptin has been
found in the synovial fluid of patients with OA 9 10
and its concentration or mRNA expression in
cartilage has been correlated with body mass index
(BMI)9 10 and female sex.7 However, it is still not
clear whether increased production of leptin is
good or bad for cartilage health9 11 with recent
evidence suggesting that leptin may act in a
biphasic manner,12 ie, leptin physiologically may
have a beneficial effect on cartilage synthesis, but
an excess of leptin may lead to detrimental effects
on cartilage.10 12 There are no in vivo data to
support this hypothesis to date.
Using MRI, we have demonstrated that BMI is
positively associated with knee cartilage defects,1 13
and fat mass is negatively associated with knee
cartilage volume.14 There are also large sex differ-
ences in knee cartilage volume in children15 and
adults2 16 17 (males have 30–40% higher cartilage
volume than females). No studies have reported on
whether leptin contributes to the BMI and sex
related differences in cartilage morphology. The
aim of this cross-sectional study, therefore, was to
determine the associations between leptin and
knee cartilage volume/defects in older adults, and
explore the possible mediating roles of leptin in
links between body mass, sex and cartilage
volume/defects.
MATERIALS AND METHODS
Subjects
The study was carried out in southern Tasmania,
Australia, from March until August 2002. Subjects
aged between 50 and 79 years were selected
randomly using computer generated random num-
bers from the electoral roll in southern Tasmania
(population 229 000), a comprehensive population
listing, with an equal number of men and women.
Institutionalised persons were excluded. This
study was conducted as part of the Tasmanian
Older Adult Cohort (TASOAC) study, an ongoing,
prospective, population-based study in 1100 sub-
jects aimed at identifying the environmental,
genetic and biochemical factors associated with
the development and progression of osteoarthritis
and osteoporosis (the overall response rate was
57%). We selected the first 190 subjects to perform
serum leptin measurement. The study was
approved by the Southern Tasmanian Health and
Medical Human Research Ethics Committee, and
written informed consent was obtained from all
participants. Self-report of smoking status and
disease status such as rheumatoid arthritis (RA),
asthma, cardiovascular disease and diabetes were
recorded by questionnaire.
Anthropometrics
Height was measured to the nearest 0.1 cm (with
shoes, socks and headgear removed) using a
stadiometer. Weight was measured to the nearest
0.1 kg (with shoes, socks and bulky clothing
removed) using a single pair of electronic scales
(Seca Delta Model 707, Bradford, Massachusetts,
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USA) that were calibrated using a known weight at the
beginning of each clinic. The body mass index (BMI; weight
(kg)/height (m2)) was calculated. Fat mass and lean mass (kg)
were measured by a Hologic dual energy x ray absorptiometry
(DXA) scanner (Hologic Corp., Waltham, Massachusetts, USA).
Percentage total body or trunk fat mass is the ratio of total body
or trunk fat mass divided by total body or trunk mass (ie, the
sum of fat mass, lean mass and bone mass).
x Ray and knee pain assessment
A standing anteroposterior semiflexed view of the right knee
with 15u of fixed knee flexion was performed in all subjects at
baseline and scored individually for osteophytes and joint space
narrowing on a scale of 0–3 (0 = normal and 3 = severe)
according to the Osteoarthritis Research Society International
(OARSI) atlas as previously described.18 The presence of
radiographic OA (ROA) was defined as any score of >1.
Knee pain (on flat surface, going up/down stairs, at night,
sitting/lying and standing upright) was assessed by self-
administered questionnaire using the Western Ontario
McMaster Osteoarthritis Index (WOMAC) with a 10-point
scale from 0 (no pain, stiffness or no function problems) to 9
(most severe pain, stiffness or severe function problems).19 Each
score of knee pain was summed to create a total pain (0–45)
score. Prevalent knee pain was defined as a total score of >1.
Knee cartilage volume measurement
Knee cartilage volume was determined by means of image
processing on an independent workstation as previously
described.15 20 The volumes of individual cartilage plates (medial
tibial, lateral tibial and patella) were isolated from the total
volume by manually drawing disarticulation contours around
the cartilage boundaries on a section by section basis. These
data were then resampled by means of bilinear and cubic
interpolation (area of 312 and 312 mm and 1.5 mm thickness,
continuous sections) for the final 3D rendering. The coefficients
of variation (CVs) for cartilage volume measures were 2.1–2.6%.
The sum of medial tibial, lateral tibial and patellar cartilage
volume was regarded as ‘‘total’’ cartilage volume.
Cartilage defects (0–4 scale) were graded at medial tibial,
medial femoral, lateral tibial, lateral femoral and patellar sites as
follows:13 21 grade 0, normal cartilage; grade 1, focal blistering
and intracartilaginous low-signal intensity area with an intact
surface and bottom; grade 2, irregularities on the surface or
bottom and loss of thickness of less than 50%; grade 3, deep
ulceration with loss of thickness of more than 50%; grade 4, full-
thickness chondral wear with exposure of subchondral bone. A
cartilage defect also had to be present in at least two
consecutive slices. A prevalent cartilage defect was defined as
Table 1 Characteristics of participants
Leptin ,
median (n = 96)
Leptin >
median (n = 94) p Values
Age, years 62.7 (7.2) 62.6 (6.9) 0.916
Female sex, % 17 79 ,0.001
Body mass index, kg/m2 26.0 (3.4) 29.1 (4.7) ,0.001
Total lean mass, kg 57.5 (9.4) 47.8 (10.0) ,0.001
Total fat mass, % 28.2 (4.7) 39.2 (5.9) ,0.001
Trunk fat mass, % 27.8 (5.3) 38.3 (5.7) ,0.001
Current smokers, % 17 15 0.889
Rheumatoid arthritis, % 8 14 0.227
Asthma, % 6 24 0.001
Cardiovascular diseases, % 5 3 0.489
Diabetes, % 3 8 0.182
Knee pain, % 40 53 0.071
Medial joint space narrowing, % 48 56 0.266
Lateral joint space narrowing, % 16 15 0.923
Medial tibiofemoral osteophytes, % 7 7 0.952
Lateral tibiofemoral osteophytes, % 3 3 0.967
Prevalent medial cartilage defects, % 25 22 0.543
Prevalent lateral cartilage defects, % 19 17 0.622
Prevalent patellar cartilage defects, % 34 44 0.194
Prevalent total cartilage defects, % 46 54 0.246
Total cartilage defects, 0–20 5.7 (2.4) 6.0 (1.9) 0.506
Medial tibial cartilage volume, ml 3.0 (0.3) 2.4 (0.5) ,0.001
Lateral tibial cartilage volume, ml 3.4 (0.7) 2.6 (0.5) ,0.001
Patellar cartilage volume, ml 3.9 (0.9) 3.1 (0.8) ,0.001
Total cartilage volume, ml 10.2 (1.6) 8.0 (1.5) ,0.001
Data shown are mean (SD) or median (interquartile range), except for percentages.
Median value of leptin: 8.7 mg/litre.
Figure 1 Scatter-plot for the association
between serum levels of leptin and total
knee cartilage volume. Log transformed
leptin was significantly associated with
knee cartilage volume (r =20.52,
p,0.001) in unadjusted analysis.
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a cartilage defect score of >2 at any site within that
compartment. Intraobserver reliability (expressed as intraclass
correlation coefficient (ICC)) was 0.89–0.94 and interobserver
reliability was 0.85–0.93.21
Tibial bone area at the medial and lateral compartments was
determined as previously described.18
Serum leptin measurement
Serum was separated and aliquotted into plastic storage tubes.
Aliquots were stored at –80uC till analysis. The levels of leptin
were measured by radioimmunoassay (LINCO Research; now
part of Millipore, Missouri, USA). Samples with undetectable
leptin concentration were assigned a value corresponding to the
lower limit of detection of the assay (0.5 mg/litre). The intra and
inter assay CVs were 4.6% and 5% respectively in our hands
Data analysis
Student t or x2 tests (where appropriate) were used to compare
means. A scatter plot and locally weighted scatterplot smooth-
ing (lowess) plot were used to depict the association between
unadjusted leptin levels and total knee cartilage volume. The
lowess command models the data locally using a cubic weighted
least squares regression, with weights that give more impor-
tance to local data points. Leptin was not normally distributed,
hence was log transformed for analyses. Univariable and
multivariable linear regression analyses were used to examine
the associations between knee cartilage volume and log
transformed leptin before and after adjustment age, sex, BMI,
smoking status, ROA, bone size, other disease status (RA,
cardiovascular disease, asthma and diabetes). The associations
between knee cartilage volume and BMI (or body fat mass) were
also investigated by linear regression after adjustment for leptin.
Similarly, univariable and multivariable logistic regression
analyses were used to examine the associations between
prevalent knee cartilage defects and log transformed leptin/
BMI/body fat mass. Standard diagnostic checks of model fit and
residuals were routinely made, and data points with large
residuals and/or high influence were investigated for data errors.
A p value ,0.05 (two-tailed) or a 95% confidence interval not
including the null point were regarded as statistically signifi-
cant. All statistical analyses were performed on SPSS V.12.0 for
Windows (SPSS, Chicago, Illinois, USA) or Stata statistical
software, V.9.2 (Stata Corp., College Station, Texas, USA).
RESULTS
A total of 190 subjects (48% female) aged between 52 and 78
(mean 63 years) participated in the present study. There were
no significant differences in demographic factors and knee
cartilage volume between the current cohort and the subjects
who did not have serum markers measured (mean (SD) age:
62.6 (7.1) vs 62.3 (7.5) years, p = 0.57; female sex: 48% vs 50%,
p = 0.62; BMI: 27.5 (4.4) vs 27.7 (4.5) kg/m2, p = 0.68; and total
cartilage volume: 9.1 (1.9) vs 9.2 (1.8) ml, p = 0.42). This is a
mixed population with 58% subjects having radiographic
changes (joint space narrowing or osteophytes score of >1) in
the right knee and 46% having knee pain. Characteristics of the
subjects are presented in table 1. Subjects with higher and lower
levels of leptin (split at the median of 8.7 mg/litre) were similar
in terms of age, smoking status, knee pain, radiographic joint
space narrowing, osteophytes, prevalent cartilage defects and
Table 2 Associations between leptin, knee cartilage volume and cartilage defects
Univariable Multivariable*
Cartilage volume, b (95% CI):
Total –1028 (–1270 to –787) –541 (–861 to –221)
Medial tibial –298 (–375 to –221) –183 (–300 to –66)
Lateral tibial –350 (–441 to –259) –161 (–294 to –28)
Patellar –380 (–501 to –260) –183 (–340 to –26)
Cartilage defects, odds ratio (95% CI):
Total 1.13 (0.84 to 1.51) 0.89 (0.52 to 1.52)
Medial tibiofemoral 0.91 (0.65 to 1.28) 0.60 (0.32 to 1.13)
Lateral tibiofemoral 1.01 (0.69 to 1.16) 1.09 (0.54 to 2.23)
Patellar 1.15 (0.85 to 1.55) 0.73 (0.43 to 1.23)
Dependent variable: cartilage volume, mm3 or prevalent castilage defects. Independent variable: leptin, per unit. Data in bold
denotes a statistically significant result.
*Adjusted for sex, age, body mass index (BMI), smoking, knee joint space narrowing, osteophytes, rheumatoid arthritis (RA),
asthma, cardiovascular diseases and cartilage defects if cartilage volume or cartilage volume if cartilage defects.
Table 3 Associations between BMI, knee cartilage volume and cartilage defects: mediating roles of leptin
Univariable Multivariable* Multivariable{ Multivariable{
Cartilage volume, b (95% CI):
Total cartilage –48 (–112 to 16) –99 (–144 to –53) –51 (–98 to –4) –2 (–61 to 56)
Medial tibial cartilage –14 (–34 to 6) –27 (–43 to –11) –14 (–32 to 3) +3 (–19 to 24)
Lateral tibial cartilage –24 (–47 to –0.4) –40 (–58 to –21) –26 (–45 to –6) –9 (–34 to 15)
Patellar cartilage –10 (–40 to 20) –31 (–55 to –8) –21 (–47 to 4) –10 (–42 to 23)
Cartilage defects, odds ratio (95% CI):
Total cartilage 1.06 (0.99 to 1.13) – 1.10 (1.01 to 1.19) 1.12 (1.01 to 1.24)
Medial tibiofemoral cartilage 1.04 (0.96 to 1.12) – 1.04 (0.94 to 1.14) 1.10 (0.98 to 1.25)
Lateral tibiofemoral cartilage 1.01 (0.93 to 1.10) – 1.01 (0.91 to 1.11) 1.00 (0.87 to 1.15)
Patellar cartilage 1.08 (1.01 to 1.16) – 1.14 (1.06 to 1.24) 1.19 (1.07 to 1.32)
Dependent variable: cartilage volume, mm3 or prevalent cartilage defects. Independent variable: body mass index (BMI), kg/m2. Data in bold denotes a statistically significant result.
*Adjusted for total lean mass; {further adjusted for sex, age, smoking, knee joint space narrowing, osteophytes, rheumatoid arthritis (RA), asthma, diabetes and cardiovascular
diseases; {further adjusted for leptin.
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total cartilage defect scores. However, subjects with higher
levels of leptin had a higher proportion of female sex, greater
BMI, less lean mass and greater % fat mass, higher prevalence of
asthma and lower cartilage volume.
Leptin levels were significantly associated with knee cartilage
volume before (fig 1, table 2) and after adjustment for sex, age,
BMI, smoking, ROA, cartilage defects and other disease status.
The associations remained largely unchanged after further
adjustment for tibial bone size. By contrast, no significant
associations were determined between prevalent cartilage
defects and leptin in univariable and multivariable analyses
(table 2).
BMI was significantly associated with leptin before and after
adjustment for covariates (partial r = 0.62, p,0.001) in this
sample. In table 3, although most associations between BMI
and knee cartilage volume in the univariable analyses were not
significant, BMI was significantly negatively associated with
knee cartilage volume after adjustment for lean mass (as total
lean mass was positively associated with total cartilage volume
(p,0.001)). The associations between BMI, and total and lateral
tibial cartilage volume remained significant after further
adjustment for other covariates; however, these associations
became non-significant after further adjustment for leptin
(table 3). In addition, BMI was significantly positively
associated with prevalent total and patellar cartilage defects
but, in contrast, these associations did not change after further
adjustment for leptin (table 3).
Percentage total fat and trunk fat mass was also positively
associated with leptin in multivariable analyses (partial r = 0.31
and r = 0.36, respectively, both p,0.001). In table 4, percentage
total fat mass and trunk fat mass were negatively associated
with knee cartilage volume. These associations decreased by 25–
30% after adjustment for leptin (table 4). By contrast, there
were no significant association between fat mass and knee
cartilage defects, and these associations were not altered by
further adjustment for leptin (data not shown).
There were large sex differences in leptin levels (women vs
men: +12 mg/litre, R2 = 43%, p,0.001) and total knee cartilage
volume (R2 = 51%, table 5). The sex difference in total knee
cartilage volume decreased substantially in magnitude but
remained significant after adjustment for leptin (R2 = 30%)
(table 5). The association between sex and prevalent total
cartilage defects was not significant in this sample (OR = 1.20,
p = 0.60), and was not influenced by adjustment for leptin.
No significant association was present between leptin and
ROA in adjusted analysis (data not shown). Subjects with
higher leptin levels had a trend to higher prevalence of knee
pain and medial joint space narrowing (JSN) but these were
not significant (table 1). The association between leptin and
medial JSN (OR = 1.10, p = 0.65) remained unchanged after
adjustment for knee pain (OR = 1.07, p = 0.76). The strength
of the associations and the evidence of mediation by leptin
did not differ when the analysis were performed separately in
men and women (data not shown). No significant interaction
was present between sex and leptin (p = 0.92) or radiographic
OA and leptin (p = 0.64) for total cartilage volume, so all data
were combined for analyses. Results remained largely
unchanged when subjects with RA, cardiovascular diseases,
diabetes, or asthma were excluded for analyses (data not
shown).
Table 4 Associations between body composition and knee cartilage volume: mediating roles of leptin
Univariable Multivariable* Multivariable{
Total cartilage, b (95% CI):
Trunk fat, % –147 (–177 to –116) –98 (–154 to –42) –75 (–134 to –16)
Total fat, % –173 (–199 to –146) –111 (–185 to –38) –80 (–156 to –5)
Medial tibial cartilage,
b (95% CI):
Trunk fat, % –41 (–51 to –31) –31 (–50 to –11) –22 (–43 to –2)
Total fat, % –47 (–56 to –38) –31 (–57 to –5) –20 (–47 to 7)
Lateral tibial cartilage,
b (95% CI)
Trunk fat, % –51 (–63 to –40) –32 (–54 to –10) –27 (–51 to –3)
Total fat, % –59 (–69 to –49) –42 (–72 to –13) –35 (–66 to –5)
Patellar cartilage, b (95% CI):
Trunk fat, % –54 (–70 to –39) –37 (–63 to –11) –30 (–58 to –2)
Total fat, % –66(–80 to –52) –46 (–81 to –10) –35 (–72 to 2)
Dependent variable: cartilage volume, mm3. Independent variable: trunk fat, or total fat mass. Data in bold denotes a statistically
significant result.
*Adjusted for sex, age, body mass index (BMI), smoking, knee joint space narrowing, osteophytes, rheumatoid arthritis (RA),
asthma and cardiovascular diseases; {further adjusted for leptin.
Table 5 Associations between sex and knee cartilage volume: mediating roles of leptin
Univariable Multivariable* Multivariable{
b (95% CI)/R2 b (95% CI)/partial R2 b (95% CI)/partial R2
Total cartilage 22764 (23154 to 22374)/R2: 51% 22669 (23076 to 22261)/R2: 51% 22174 (22694 to 21654)/R2: 30%
Medial tibial cartilage 2763 (2896 to 2629)/R2: 40% 2704 (2847 to 2560)/R2: 37% 2531 (2715 to 2348)/R2: 17%
Lateral tibial cartilage 2909 (21066 to 2752)/R2: 41% 2861 (21025 to 2697)/R2: 40% 2699 (2910 to 2489)/R2: 21%
Patellar cartilage 21092 (21300 to 2885)/R2: 36% 21046 (21265 to 2828)/R2: 34% 2909 (21196 to 2621)/R2: 18%
Dependent variable: cartilage volume, mm3. Independent variable: sex (men = 0, women = 1). All results were statistically significant.
*Adjusted for age, body mss index (BMI), smoking, knee joint space narrowing, osteophytes, rheumatoid arthritis (RA), asthma, diabetes and cardiovascular diseases; {further
adjusted for leptin.
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DISCUSSION
This study reports a consistent negative association between
serum leptin levels and knee cartilage volume (both total and in
all compartments) in older adults with or without radiographic
OA. This was independent of BMI and sex. Conversely, the
associations between BMI, body fat mass, sex and knee cartilage
volume were not independent of serum leptin levels. Lastly, the
association between BMI and prevalent knee cartilage defects
was not related to leptin.
Assessment of cartilage volume and cartilage defects by MRI,
with fat-suppressed gradient echo sequences, and appropriate
image analysis techniques, has high accuracy and adequate
precision for cross-sectional and longitudinal studies in healthy
subjects and patients with OA.22 23 Cartilage defects and volume
are both important in OA. Cartilage defects seem to represent
an early stage of cartilage damage and predict cartilage volume
loss in a number of studies.23 Independent to the association
with cartilage defects, cartilage volume is also impacted on by
other structural and, based on this study, hormonal factors. We
found that higher serum leptin levels were significantly
associated with lower knee cartilage volume at all three sites.
This is in line with a recent in vitro study that suggested that
leptin and its receptor (ob-Rb) mRNA was expressed at
significantly higher levels in osteoarthritic compared to normal
cartilage, and leptin had a detrimental effect on chondrocyte
proliferation and induced matrix metalloproteinase (MMP) 9
and 13 protein expression.10 Although studies suggest that leptin
levels are higher in synovial fluid than in serum,10 24 our data
clearly demonstrates that serum leptin levels are associated with
reduced knee cartilage volume in one knee, suggesting a
systemic hormonal influence on cartilage volume. Whether this
reflects a systemic effect on other joints with hyaline cartilage is
unknown, but is deserving of further study. The associations
between leptin and knee cartilage volume remained significant
after adjustment for BMI, suggesting its effects on knee cartilage
are independent of BMI. Of note, we found that medial joint
space narrowing scores were worse in subjects with high leptin
levels (.median value) but this was not significant, most likely
indicating lower sensitivity for radiographs compared with
MRI. A more sensitive protocol for the radiography, eg, the
Lyon schuss view, may show such a difference or it may be that
all radiographs lack sensitivity.
Consistent with our previous report,1 BMI was not signifi-
cantly associated with knee cartilage volume in unadjusted
analysis. However, BMI was significantly negatively associated
with knee cartilage volume when the protective effect of lean
mass was taken into account (by adjustment for lean mass).
Similarly, fat mass was negatively associated with knee cartilage
volume, which is also consistent with a recent report.14 The
associations of BMI and fat mass with cartilage volume were
dependent on leptin, suggesting that at least some of the
association between obesity and cartilage volume is hormonally
linked rather than purely mechanical. By contrast, we did not
find significant associations between serum leptin and knee
focal cartilage defects even though cartilage defects were
significantly associated with loss of cartilage volume.23
Although obesity was associated with cartilage defects as we
have previously reported,1 adjustment for leptin did little to this
suggesting cartilage splitting or focal defects are more suscep-
tible to mechanical loading25 than hormonal effects.
Males have consistently higher knee cartilage volumes than
females,15–17 26 as seen in the findings from this study. This is
predominantly due to greater body size. Other factors may
include sex hormones and growth factors.16 Variation in leptin
may be another contributor. Indeed, we found that older
females had significantly greater serum leptin levels than older
males, and sex differences in knee cartilage volume decreased
substantially in magnitude after adjustment for leptin providing
support for this hypothesis.
Our study has several potential limitations. First, the sample
size was relatively small, which may miss moderate associa-
tions; however, significant associations between leptin and knee
cartilage volume were detected using this sample size. Second,
the response rate at baseline was 57%, which may leave the
possibility open for selection bias although there were no
differences between those reported in this study and the rest of
the cohort. Third, this randomly selected sample contained
subjects with other diseases. However, the results were largely
unchanged when the analyses were adjusted for disease status
or these subjects were excluded. Fourth, we used tibial cartilage
as the measure of joint cartilage at the tibiofemoral joint rather
that femoral cartilage, and it is possible that associations with
femoral cartilage are different to those with tibial cartilage.27
However, we have previously shown a strong correlation
between the tibial and femoral cartilage in the medial and
lateral tibiofemoral compartments.28 It would be worthwhile to
examine associations at other sites, eg, hip and spinal discs.
Fifth, measurement error may influence results. However, all
measures were highly reproducible suggesting this is unlikely.
Lastly, due to cross-sectional nature, this study cannot exclude
the possible confounding effect on cartilage volume measure-
ments of hypertrophic repair or swelling in OA cartilage. The
cause effect relationship between obesity, sex, leptin and
cartilage needs to be elucidated by longitudinal studies.
In conclusion, this cross-sectional study suggests that
cartilage volume loss with obesity and female sex is related to
leptin and, thus, is hormonally mediated in older adults. By
contrast, obesity related knee focal cartilage defects may be
more related to non-hormonal factors.
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